AzTrials
AzTrials

Malocclusion, Angle Class II, Division 1NCT07466641

LLLLT vs Piezocision in Accelerating Orthodontic Canine Retraction

A study testing Low Level Laser Therapy and Piezocision in people with Malocclusion, Angle Class II, Division 1 and Bimaxillary Protrusion, run by Hesham Nabil Ali Al-Qamhawy at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This comparative controlled clinical study aims to evaluate and compare the effectiveness of piezocision and low-level laser therapy (LLLT) as adjunctive interventions to accelerate orthodontic canine retraction. Read more about this study

Who is it for?
Ages 18 to 25 years
What is being tested?
Low Level Laser Therapy and Piezocision
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
21 participants
Where
1 siteEgypt
Study dates
1 Apr 2026to Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Age range 18-25 years.
  • Patients with crowding or protrusion requiring at least bilateral maxillary first premolar extraction followed by symmetrical canine retraction.
  • Full set of permanent dentition (third molar not considered).
  • Patients with good oral hygiene.

Who cannot join

  • Previous orthodontic treatment.
  • Patients taking medications or suffering from systemic conditions that can affect orthodontic tooth movement.
  • Active periodontal diseases and/or untreated carious lesions.
  • Congenital orofacial deformities.
  • Discontinuation criteria:
  • Multiple missing appointments.
  • Poor oral hygiene.
  • Multiple broken appliances to the extent that interferes with obtaining the treatment objectives.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Hesham N Al-Qamhawy contact

00201099767929

heshamnabil96@gmail.com

Egypt1 site, 1 recruiting
  • Outpatient Clinics of the Department of Orthodontics, Faculty of Dental Medicine, Boys, Cairo, Al-Azhar University.

    Cairo, Cairo Governorate

    Recruiting

Other trials in Egypt

About this study

Official title: Effectiveness of Piezocision Versus Low-level Laser Therapy During Orthodontic Canine Retraction: A Comparative Controlled Clinical Study

This comparative controlled clinical study aims to evaluate and compare the effectiveness of piezocision and low-level laser therapy (LLLT) as adjunctive interventions to accelerate orthodontic canine retraction. Participants will be randomly assigned to one of three groups: piezocision, LLLT, or a control group (no adjunctive procedure). The study will assess the impact of these interventions on the rate of tooth movement, the type of tooth movement, and patient experience.

Being tested
Low Level Laser Therapy, Piezocision
Keywords
canine retraction, Low-level laser therapy, laser, piezocision, piezosurgery, orthodontic canine retraction
Medical subject headings
Malocclusion, Angle Class II, Malocclusion, Angle Class I

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low Level Laser TherapyProcedure or surgery

    Also called LLLT

    On both right and left sides, LLLT will be performed at the beginning of canine retraction, after 3, 7, 14 days, and then every 14 days for a total four-month period.

  • PiezocisionProcedure or surgery

    Also called Piezosurgery

    On both right and left sides, a minimally invasive flapless piezocision procedure will be performed each month from the beginning of the canine retraction for a total four-month period.

Study groups in NCT07466641
Study groupRoleWhat they receive
Low-level laser therapy groupExperimentalNot described
Receives: Procedure: Low Level Laser Therapy
Piezocision groupExperimentalNot described
Receives: Procedure: Piezocision
Control groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of canine retraction

    The rate of distal movement of the maxillary canine measured in millimeters per month (mm/month).

    Measured: Four months from the beginning of maxillary canine retraction.

Secondary outcomes (4)
  1. Maxillary canine rotation and tipping.

    Measured in degrees

    Measured: Four months from the beginning of maxillary canine retraction.

  2. Maxillary first molar mesial movement

    Maxillary first molar mesial movement (measured in mm)

    Measured: Four months from the beginning of maxillary canine retraction.

  3. Maxillary first molar rotatiob

    (measured in degrees).

    Measured: Four months from the beginning of maxillary canine retraction.

  4. Patient-Reported Pain Intensity

    Pain intensity will be measured using a 10-centimeter Visual Analogue Scale (VAS). The scale ranges from 0 to 10, where 0 represents "no pain" and 10 represents "the worst possible pain" . Therefore, higher scores indicate a worse outcome (greater pain intensity).

    Measured: Four months from the beginning of maxillary canine retraction.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2026
  2. Study start1 Apr 2026
  3. Primary completionFeb 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
21 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07466641
Sponsor's protocol ID
1440/1511
Status last verified
May 2026
First submitted
3 Mar 2026
Last updated
11 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Low Level Laser Therapy and Piezocision in people with Malocclusion, Angle Class II, Division 1 and Bimaxillary Protrusion, run by Hesham Nabil Ali Al-Qamhawy at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Hesham N Al-Qamhawy (00201099767929, heshamnabil96@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of canine retraction (time frame: Four months from the beginning of maxillary canine retraction.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in